Today: 30 April 2026
Broadcom stock dips to $320 as Intel shock hits chips; Fed week and VMware dispute loom
24 January 2026
1 min read

Broadcom stock dips to $320 as Intel shock hits chips; Fed week and VMware dispute loom

New York, January 24, 2026, 10:06 (EST) — Market closed.

  • Shares of Broadcom ended Friday 1.7% lower, closing at $320.05 after fluctuating between $314.19 and $326.90 during the session
  • After Intel’s weak outlook, chip sentiment turned choppy as investors prepared for a Fed decision and a packed earnings week
  • A Fidelity settlement involving access to Broadcom’s VMware software has reignited concerns over contract disputes

Shares of Broadcom Inc (AVGO.O) slipped 1.7% to finish at $320.05 on Friday, on volume around 30.3 million. The stock swung between a low of $314.19 and a high of $326.90 during the session.

Why it matters now: Broadcom is at the heart of the AI trade debate—investors are scrutinizing if data center spending is finally translating into profits. Rate expectations continue to sway tech valuations. Yung-Yu Ma, chief investment strategist at PNC Financial Services Group, described the recent market swings as a “short but steep roller-coaster ride.” Meanwhile, Franklin Templeton’s Chris Galipeau cautioned that the S&P 500’s valuation “had better be met” by earnings. Reuters

Intel shares plunged 17% on Friday after the company forecasted quarterly revenue and profit below market expectations, citing challenges in meeting demand for server chips powering AI data centers. Julian McManus, portfolio manager on Janus Henderson’s Global Alpha Equity team, called it a “show-me” period. Reuters

Fidelity Investments announced it has settled a lawsuit claiming Broadcom threatened to block access to VMware’s “business-critical” virtualization software, which enables firms to run multiple virtual servers on one physical machine. Broadcom has agreed to continue supplying these services and software to a Fidelity subsidiary. A Fidelity spokesperson confirmed the dispute won’t affect its operations. Reuters

Broadcom’s tale splits into two: semiconductors driven by cloud and networking demand, and infrastructure software anchored by VMware. These businesses rarely pause together, and each can push the stock one way or the other.

As Monday’s reopen approaches, traders will be eyeing any spillover from Intel’s warning across the chip sector. The key question: Is this just an Intel issue, or a sign of softer demand? Broadcom usually tracks the data-center group, shifting with risk-on or risk-off flows.

The “Magnificent Seven” mega-cap tech giants still hold sway over index moves. When they boost AI budget talks, chip suppliers often get a lift. But a hint of belt-tightening, and the momentum can vanish quickly.

The risks stand out clearly. If the Federal Reserve shifts to a hawkish stance, rate-sensitive tech multiples could take a hit. Plus, fresh customer resistance to VMware’s contract terms might keep legal challenges and renewal doubts in the spotlight.

The Federal Reserve’s policy decision on Jan. 28 at 2:00 p.m. ET stands out as the week’s clearest scheduled catalyst, with Chair Jerome Powell’s press conference set for 2:30 p.m. ET.

Stock Market Today

  • Why Investors Are Focused on Vaidya Sane Ayurved Laboratories (NSE:MADHAVBAUG) Amid Growth and High Insider Ownership
    April 29, 2026, 10:29 PM EDT. Vaidya Sane Ayurved Laboratories (NSE:MADHAVBAUG) has attracted investor attention due to its strong financial performance and insider alignment. The company has delivered a compound annual EPS growth of 19% over the past three years, signaling sustained earnings momentum. Revenue growth and an improved EBIT margin, up by 6.6 percentage points to 11%, underscore operational strength. With insiders owning 78% of the firm, alignment between management and shareholders is notably high, reducing agency risk. Valued at ₹2.5 billion, the company appeals to investors favoring profitable, growing firms over speculative ventures without revenue or profit history. This combination of growth, profitability, and insider confidence makes Vaidya Sane a compelling pick in the Ayurvedic healthcare sector.

Latest article

Soluna Holdings Stock Jumps After Sazmining Bitcoin Deal, Then SEC Resale Filing Lands

Soluna Holdings Stock Jumps After Sazmining Bitcoin Deal, Then SEC Resale Filing Lands

30 April 2026
Soluna Holdings filed to register the resale of about 2.46 million common shares, with no proceeds going to the company. The move follows Sazmining’s launch of a 3-megawatt Bitcoin mining operation at Soluna’s Project Dorothy 1B in West Texas. Soluna shares last traded at $1.28, up from a $1.08 Nasdaq sale price on April 28. The registered shares include 2.4 million issuable to YA II PN, LTD. via warrant exercise.
Brookfield Renewable Stock Drops 12% Before Q1 Results as BEPC Investors Brace for Friday

Brookfield Renewable Stock Drops 12% Before Q1 Results as BEPC Investors Brace for Friday

30 April 2026
Brookfield Renewable Corp’s NYSE shares fell 12.5% to $35.20 on Wednesday, with volume quadrupling the three-month average ahead of first-quarter results due Friday. The drop came despite a higher quarterly dividend and mixed analyst views. The company operates 47 GW of clean energy assets globally. Analysts expect a first-quarter loss of 33.92 cents per share on $1.62 billion in revenue.
Apple stock price: China discounts and India antitrust hearing put AAPL in focus before earnings week
Previous Story

Apple stock price: China discounts and India antitrust hearing put AAPL in focus before earnings week

Exxon stock price: XTO’s Eagle Ford sale push puts XOM in play ahead of key week
Next Story

Exxon stock price: XTO’s Eagle Ford sale push puts XOM in play ahead of key week

Go toTop